Literature DB >> 24866250

Unilateral renal oncocytosis and combined hybrid tumor: a case report and review of the literature.

Mack Shin1, Sung Bin Park, Jong Beum Lee, Hyun Jeong Park, In Ho Chang, Tae-Jin Lee.   

Abstract

Renal oncocytosis is a very rare cause of multiple renal masses. Imaging features of renal oncocytosis and combined tumors have rarely been reported. Here, we describe a case of unilateral left renal oncocytosis and a combined hybrid tumor between chromophobe renal cell carcinoma and oncocytoma, which were depicted on CT and MR imaging as multiple enhancing solid masses with one dominant mass. Additionally, we reviewed the literature.

Entities:  

Mesh:

Year:  2014        PMID: 24866250     DOI: 10.1007/s11604-014-0334-9

Source DB:  PubMed          Journal:  Jpn J Radiol        ISSN: 1867-1071            Impact factor:   2.374


  14 in total

1.  Is segmental enhancement inversion on enhanced biphasic MDCT a reliable sign for the noninvasive diagnosis of renal oncocytomas?

Authors:  John P McGahan; Ramit Lamba; Jerron Fisher; Phillip Starshak; Rajendra Ramsamooj; Evan Fitzgerald; Philip Yen
Journal:  AJR Am J Roentgenol       Date:  2011-10       Impact factor: 3.959

2.  Renal oncocytosis: management and clinical outcomes.

Authors:  Ari Adamy; William T Lowrance; David S Yee; Kian Tai Chong; Melanie Bernstein; Satish K Tickoo; Jonathan A Coleman; Paul Russo
Journal:  J Urol       Date:  2011-01-15       Impact factor: 7.450

3.  Renal oncocytomatosis.

Authors:  K A Warfel; J N Eble
Journal:  J Urol       Date:  1982-06       Impact factor: 7.450

Review 4.  Renal oncocytosis.

Authors:  Yoji Nagashima; Toshiyuki Mitsuya; Ko-ich Shioi; Sumio Noguchi; Takeshi Kishida; Atsushi Hamano; Yoshiharu Ohgo; Yukio Tsuura; Toru Ogawa; Ichiro Aoki; Masahiro Yao
Journal:  Pathol Int       Date:  2005-04       Impact factor: 2.534

5.  Spoke-wheel-like enhancement as an important imaging finding of chromophobe cell renal carcinoma: a retrospective analysis on computed tomography and magnetic resonance imaging studies.

Authors:  Tsunenori Kondo; Hayakazu Nakazawa; Fumikazu Sakai; Tomo Kuwata; Shiro Onitsuka; Yasunobu Hashimoto; Hiroshi Toma
Journal:  Int J Urol       Date:  2004-10       Impact factor: 3.369

Review 6.  Genetic basis for kidney cancer: opportunity for disease-specific approaches to therapy.

Authors:  Elizabeth Cartwright Pfaffenroth; W Marston Linehan
Journal:  Expert Opin Biol Ther       Date:  2008-06       Impact factor: 4.388

Review 7.  Management of the incidental renal mass.

Authors:  Stuart G Silverman; Gary M Israel; Brian R Herts; Jerome P Richie
Journal:  Radiology       Date:  2008-10       Impact factor: 11.105

Review 8.  Hereditary renal cancers.

Authors:  Peter L Choyke; Gladys M Glenn; McClellan M Walther; Berton Zbar; W Marston Linehan
Journal:  Radiology       Date:  2003-01       Impact factor: 11.105

9.  Segmental enhancement inversion at biphasic multidetector CT: characteristic finding of small renal oncocytoma.

Authors:  Jung Im Kim; Jeong Yeon Cho; Kyung Chul Moon; Hak Jong Lee; Seung Hyup Kim
Journal:  Radiology       Date:  2009-06-09       Impact factor: 11.105

10.  Comparison of segmental enhancement inversion on biphasic MDCT between small renal oncocytomas and chromophobe renal cell carcinomas.

Authors:  Sungmin Woo; Jeong Yeon Cho; Seung Hyup Kim; Sang Youn Kim
Journal:  AJR Am J Roentgenol       Date:  2013-09       Impact factor: 3.959

View more
  2 in total

1.  Computed Tomography Appearance of Renal Hybrid Oncocytic/Chromophobe Tumors.

Authors:  Akrita Bhatnagar; Steven P Rowe; Michael A Gorin; Martin G Pomper; Elliot K Fishman; Mohamad E Allaf
Journal:  J Comput Assist Tomogr       Date:  2016 Jul-Aug       Impact factor: 1.826

Review 2.  [The diagnostic and therapeutic challenges of bilateral renal oncocytosis : Illustrative case presentations and a review of the literature].

Authors:  M Janssen; M Eckerl; J Moersler; M Rotter; M May; C Gilfrich
Journal:  Urologe A       Date:  2016-07       Impact factor: 0.639

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.